The respiratory theme of the NIHR Nottingham Biomedical Research Centre has recruited the first patient in the UK into the AERIFY-3 study.
Dr Samuel Kemp of the NUH Complex COPD Service is the Investigator for the study with senior research nurse Chloe Khurana leading and managing the study.
What is AERIFY-3
AERIFY-3: A multi-center, worldwide, clinical study for people diagnosed with chronic obstructive pulmonary disease (COPD).
What is the study about?
COPD is a serious and life-threatening disease. Symptoms include frequent coughing, wheezing and excess mucus. People living with COPD can experience airflow blockage and breathing-related problems. Although there is no cure for COPD, it can be treated.
This study will research how the investigational medication works and how it impacts airway inflammation in patients with COPD, who continue to have symptoms on current treatment
Huge thank you to Wayne for being the first participant in the UK to take part in the AERIFY-3 study
